AAAAAA

   
Results: 1-8 |
Results: 8
3-deoxy-3-substituted-D-myo-inositol imidazolyl ether lipid phosphates andcarbonate as inhibitors of the phosphatidylinositol 3-kinase pathway and cancer cell growth
Authors: Hu, YH Meuillet, EJ Berggren, M Powis, G Kozikowski, AP
Citation: Yh. Hu et al., 3-deoxy-3-substituted-D-myo-inositol imidazolyl ether lipid phosphates andcarbonate as inhibitors of the phosphatidylinositol 3-kinase pathway and cancer cell growth, BIOORG MED, 11(2), 2001, pp. 173-176
Molecular modeling studies of the Akt PH domain and its interaction with phosphoinositides
Authors: Rong, SB Hu, YH Enyedy, I Powis, G Meuillet, EJ Wu, XW Wang, RX Wang, SM Kozikowski, AP
Citation: Sb. Rong et al., Molecular modeling studies of the Akt PH domain and its interaction with phosphoinositides, J MED CHEM, 44(6), 2001, pp. 898-908
Synthesis and Akt inhibitory properties of a 1D-3,4-dideoxyphosphatidylinositol ether lipid
Authors: Hu, YH Meuillet, EJ Qiao, LX Berggren, MM Powis, G Kozikowski, AP
Citation: Yh. Hu et al., Synthesis and Akt inhibitory properties of a 1D-3,4-dideoxyphosphatidylinositol ether lipid, TETRAHEDR L, 41(39), 2000, pp. 7415-7418
3-(Hydroxymethyl)-bearing phosphatidylinositol ether lipid analogues and carbonate surrogates block PI3-K, Akt, and cancer cell growth
Authors: Hu, YH Qiao, LX Wang, SM Rong, SB Meuillet, EJ Berggren, M Gallegos, A Powis, G Kozikowski, AP
Citation: Yh. Hu et al., 3-(Hydroxymethyl)-bearing phosphatidylinositol ether lipid analogues and carbonate surrogates block PI3-K, Akt, and cancer cell growth, J MED CHEM, 43(16), 2000, pp. 3045-3051
Modulation of EGF receptor activity by changes in the GM3 content in a human epidermoid carcinoma cell line, A431
Authors: Meuillet, EJ Mania-Farnell, B George, D Inokuchi, J Bremer, EG
Citation: Ej. Meuillet et al., Modulation of EGF receptor activity by changes in the GM3 content in a human epidermoid carcinoma cell line, A431, EXP CELL RE, 256(1), 2000, pp. 74-82
Incorporation of exogenous lipids modulates insulin signaling in the hepatoma cell line, HepG2
Authors: Meuillet, EJ Leray, V Hubert, P Leray, C Cremel, G
Citation: Ej. Meuillet et al., Incorporation of exogenous lipids modulates insulin signaling in the hepatoma cell line, HepG2, BBA-MOL BAS, 1454(1), 1999, pp. 38-48
Metformin modulates insulin receptor signaling in normal and cholesterol-treated human hepatoma cells (HepG2)
Authors: Meuillet, EJ Wiernsperger, N Mania-Farnell, B Hubert, P Cremel, G
Citation: Ej. Meuillet et al., Metformin modulates insulin receptor signaling in normal and cholesterol-treated human hepatoma cells (HepG2), EUR J PHARM, 377(2-3), 1999, pp. 241-252
Sialidase gene transfection enhances epidermal growth factor receptor activity in an epidermoid carcinoma cell line, A431
Authors: Meuillet, EJ Kroes, R Yamamoto, H Warner, TG Ferrari, J Mania-Farnell, B George, D Rebbaa, A Moskal, JR Bremer, EG
Citation: Ej. Meuillet et al., Sialidase gene transfection enhances epidermal growth factor receptor activity in an epidermoid carcinoma cell line, A431, CANCER RES, 59(1), 1999, pp. 234-240
Risultati: 1-8 |